StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)

Close on Nov 17, 2026Market cap $110.08MP/E –Yield –

Journey Medical price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Journey Medical's price to book ratio was 3.7× on Nov 11, 2026, against 7.2× a year earlier. Over the last 5 years it ranged from 0.7× to 10.4×, with a median of 5.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.7×−3.2
2025Dec 31, 20256.9×−0.2
2024Dec 31, 20247.1×+1.3
2023Dec 29, 20235.8×+4.6
2022Dec 30, 20221.2×–

More Journey Medical figures

See a number that looks wrong?